NO178665C - Fosfopeptider og sammensetning for kosmetiske formål - Google Patents

Fosfopeptider og sammensetning for kosmetiske formål

Info

Publication number: NO178665C
Authority: NO; Norway
Prior art keywords: phosphopeptides; composition; cosmetic purposes; compositions; phosphohistidine
Prior art date: 1986-06-12

Application number

NO880589A

Other languages

English (en)

Norwegian (no)

Other versions

NO880589D0 (no

NO178665B (no

NO880589L (no

Inventor

Eric Charles Reynolds

Original Assignee

Univ Melbourne

Victorian Dairy Ind

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-06-12

Filing date

1988-02-10

Publication date

1996-05-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3771654&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO178665(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1988-02-10 Application filed by Univ Melbourne, Victorian Dairy Ind filed Critical Univ Melbourne

1988-02-10 Publication of NO880589D0 publication Critical patent/NO880589D0/no

1988-04-06 Publication of NO880589L publication Critical patent/NO880589L/no

1996-01-29 Publication of NO178665B publication Critical patent/NO178665B/no

1996-05-08 Publication of NO178665C publication Critical patent/NO178665C/no

Links

239000000203 mixture Substances 0.000 title abstract 3
108010001441 Phosphopeptides Proteins 0.000 title abstract 2
239000002537 cosmetic Substances 0.000 title 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
BZQFBWGGLXLEPQ-UHFFFAOYSA-N O-phosphoryl-L-serine Natural products OC(=O)C(N)COP(O)(O)=O BZQFBWGGLXLEPQ-UHFFFAOYSA-N 0.000 abstract 1
229940024606 amino acid Drugs 0.000 abstract 1
150000001413 amino acids Chemical class 0.000 abstract 1
229940009098 aspartate Drugs 0.000 abstract 1
229950006137 dexfosfoserine Drugs 0.000 abstract 1
229930195712 glutamate Natural products 0.000 abstract 1
FDIKHVQUPVCJFA-UHFFFAOYSA-N phosphohistidine Chemical compound OP(=O)(O)NC(C(=O)O)CC1=CN=CN1 FDIKHVQUPVCJFA-UHFFFAOYSA-N 0.000 abstract 1
BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 abstract 1
USRGIUJOYOXOQJ-GBXIJSLDSA-N phosphothreonine Chemical compound OP(=O)(O)O[C@H](C)[C@H](N)C(O)=O USRGIUJOYOXOQJ-GBXIJSLDSA-N 0.000 abstract 1
DCWXELXMIBXGTH-UHFFFAOYSA-N phosphotyrosine Chemical compound OC(=O)C(N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-UHFFFAOYSA-N 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Birds (AREA)
Oral & Maxillofacial Surgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Cosmetics (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Cereal-Derived Products (AREA)
Bakery Products And Manufacturing Methods Therefor (AREA)
General Preparation And Processing Of Foods (AREA)
Non-Alcoholic Beverages (AREA)

NO880589A 1986-06-12 1988-02-10 Fosfopeptider og sammensetning for kosmetiske formål NO178665C (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AUPH638586		1986-06-12
PCT/AU1987/000172 WO1987007615A1 (en)	1986-06-12	1987-06-12	Phosphopeptides

Publications (4)

Publication Number	Publication Date
NO880589D0 NO880589D0 (no)	1988-02-10
NO880589L NO880589L (no)	1988-04-06
NO178665B NO178665B (no)	1996-01-29
NO178665C true NO178665C (no)	1996-05-08

Family

ID=3771654

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO880589A NO178665C (no)	1986-06-12	1988-02-10	Fosfopeptider og sammensetning for kosmetiske formål

Country Status (12)

Country	Link
EP (1)	EP0268663B1 (de)
JP (1)	JPH0776235B2 (de)
AT (1)	ATE132161T1 (de)
BR (1)	BR8707352A (de)
CA (1)	CA1315480C (de)
DE (1)	DE3751652T2 (de)
DK (1)	DK173565B1 (de)
FI (1)	FI92709C (de)
HU (1)	HUT47309A (de)
NO (1)	NO178665C (de)
NZ (1)	NZ220673A (de)
WO (1)	WO1987007615A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4606674A (en) *	1984-04-23	1986-08-19	Capron Mark E	Structural wheel element
GB8811829D0 (en) *	1988-05-19	1988-06-22	Unilever Plc	Oral compositions
GB8811830D0 (en) *	1988-05-19	1988-06-22	Unilever Plc	Oral compositions
DK0391629T3 (da) *	1989-04-07	1997-12-15	Univ South Alabama	Inhibering af mineralaflejring ved hjælp af phosphorylerede og beslægtede polyanioniske peptider
US5290685A (en) *	1990-02-22	1994-03-01	Meiji Milk Products Company Limited	Method for separation and concentration of phosphopeptides
DE4007431A1 (de) *	1990-03-09	1991-09-12	Henkel Kgaa	Den zahnschmelz schuetzende mund- und zahnpflegemittel
EP0523776A3 (en) *	1991-07-17	1993-05-26	Unilever N.V.	Oral compositions containing a phosphopeptide
GB9117315D0 (en) *	1991-08-09	1991-09-25	Unilever Plc	Method of controlling dental tartar and compositions for use therein
DK0651652T3 (da) *	1992-06-29	2000-07-24	Univ Melbourne	Behandling af sensitive tænder
CA2181109A1 (en) *	1995-07-18	1997-01-19	Nobuko Imajo	Polypeptide and process for measuring living body components using the same
US5837674A (en)	1996-07-03	1998-11-17	Big Bear Bio, Inc.	Phosphopeptides and methods of treating bone diseases
AUPO566297A0 (en)	1997-03-13	1997-04-10	University Of Melbourne, The	Calcium phosphopeptide complexes
AUPP051497A0 (en) *	1997-11-24	1997-12-18	University Of Melbourne, The	Antimicrobial peptides
AUPP494798A0 (en)	1998-07-29	1998-08-20	Pacific Biolink Pty Limited	Protective protein formulation
CA2359647C (en) *	1999-03-25	2003-12-30	Warner-Lambert Company	Oral care chewing gums and confections
US6846500B1 (en) *	1999-03-25	2005-01-25	Cadbury Adams Usa Llc	Oral care chewing gums and method of use
AUPR517701A0 (en)	2001-05-21	2001-06-14	University Of Melbourne, The	Dental restorative materials
AU2005306869B2 (en)	2004-11-16	2011-11-10	3M Innovative Properties Company	Dental fillers including a phosphoruscontaining surface treatment
CA2587278A1 (en) *	2004-11-16	2006-05-26	3M Innovative Properties Company	Dental fillers, methods, compositions including a caseinate
AU2005306857A1 (en)	2004-11-16	2006-05-26	3M Innovative Properties Company	Dental compositions with calcium phosphorus releasing glass
CN101098673B (zh)	2004-11-16	2012-02-29	3M创新有限公司	包括磷酸盐的牙科填料和组合物
WO2006056013A1 (en) *	2004-11-25	2006-06-01	The University Of Melbourne	Stabilized calcium phosphate complexes
CA2611077C (en)	2005-06-07	2014-07-15	The University Of Melbourne	Dental mineralization
PL1901702T3 (pl) *	2005-06-24	2015-07-31	Univ Melbourne	Kompleksy jonowe
US20090130191A1 (en)	2005-10-27	2009-05-21	Sunstar Inc.	Osteoclast Growth Inhibitor, Oral Composition, and Preventive or Therapeutic Agent for Bone Diseases, Containing Liposome-Encapsulated Lactoferrin
AU2007214265B2 (en)	2006-02-09	2012-06-14	The University Of Melbourne	Fluoride composition and methods for dental mineralization
PL3024428T3 (pl)	2013-07-23	2021-07-05	The University Of Melbourne	Kompozycje i sposoby mineralizacji zębów
RU2716134C2 (ru)	2013-12-24	2020-03-06	Де Юниверсити Оф Мельбурн	Стабилизированные композиции на основе олова (II)
KR102862249B1 (ko)	2017-03-14	2025-09-19	더 유니버시티 오브 멜버른	치은염을 위한 치료
EA201991935A1 (ru)	2017-03-14	2020-02-14	Де Юниверсити Оф Мельбурн	Комплексы для лечения чувствительности
CA3133097A1 (en)	2019-03-13	2020-09-17	The University Of Melbourne	Compositions and methods for promoting mineralization

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU520417B2 (en) *	1977-09-07	1982-01-28	Sandoz Ltd	Pentapeptides and derivatives
FR2474828B1 (fr) *	1980-02-01	1983-09-09	Agronomique Inst Nat Rech	Procede de traitement d'une matiere premiere a base de caseine, contenant des phosphocaseinates de cations bivalents, produits obtenus et application
FR2474829B1 (fr) *	1980-02-01	1983-09-09	Agronomique Inst Nat Rech	Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
NZ199891A (en) *	1981-03-04	1985-07-31	Univ Melbourne	Caries-inhibiting compositions containing casein or x-s-casein or phosuitin
US4463092A (en) *	1982-09-27	1984-07-31	Eli Lilly And Company	Process for production antibiotic A53868
DE3320175A1 (de) *	1983-06-03	1984-12-06	Boehringer Mannheim Gmbh, 6800 Mannheim	Aminosaeure- bzw. peptidderivate, verfahren zu deren herstellung und verwendung als arzneimittel

1987
- 1987-06-11 CA CA000539452A patent/CA1315480C/en not_active Expired - Lifetime
- 1987-06-12 JP JP62503719A patent/JPH0776235B2/ja not_active Expired - Lifetime
- 1987-06-12 NZ NZ220673A patent/NZ220673A/xx unknown
- 1987-06-12 DE DE3751652T patent/DE3751652T2/de not_active Expired - Lifetime
- 1987-06-12 BR BR8707352A patent/BR8707352A/pt unknown
- 1987-06-12 AT AT87904015T patent/ATE132161T1/de not_active IP Right Cessation
- 1987-06-12 HU HU873314A patent/HUT47309A/hu unknown
- 1987-06-12 EP EP87904015A patent/EP0268663B1/de not_active Expired - Lifetime
- 1987-06-12 WO PCT/AU1987/000172 patent/WO1987007615A1/en not_active Ceased
1988
- 1988-02-10 NO NO880589A patent/NO178665C/no unknown
- 1988-02-11 DK DK198800703A patent/DK173565B1/da not_active IP Right Cessation
- 1988-02-11 FI FI880629A patent/FI92709C/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA1315480C (en)	1993-03-30
NO880589D0 (no)	1988-02-10
EP0268663A4 (de)	1990-04-10
DK70388D0 (da)	1988-02-11
BR8707352A (pt)	1988-09-13
DE3751652T2 (de)	1996-07-25
ATE132161T1 (de)	1996-01-15
HUT47309A (en)	1989-02-28
FI92709C (fi)	1994-12-27
DE3751652D1 (en)	1996-02-08
JPH0776235B2 (ja)	1995-08-16
FI92709B (fi)	1994-09-15
NZ220673A (en)	1990-05-28
AU593365B2 (en)	1990-02-08
FI880629A0 (fi)	1988-02-11
NO178665B (no)	1996-01-29
DK173565B1 (da)	2001-03-19
EP0268663A1 (de)	1988-06-01
AU7548387A (en)	1988-01-11
EP0268663B1 (de)	1995-12-27
NO880589L (no)	1988-04-06
FI880629L (fi)	1988-02-11
WO1987007615A1 (en)	1987-12-17
DK70388A (da)	1988-04-11
JPS63503459A (ja)	1988-12-15

Publication	Publication Date	Title
ATE132161T1 (de)	1996-01-15	Phosphopeptide
DK0792287T3 (da)	2004-08-30	Peptidanaloger af humant basisk myelinprotein
DE69839424D1 (de)	2008-06-12	Nukleinsäure bindende proteine
DE59401383D1 (de)	1997-02-06	Verfahren zur Herstellung von aminosubstituierten Thioethern
ATE130288T1 (de)	1995-12-15	Verfahren zur radiomarkierung von proteinen.
BR9713404A (pt)	2000-01-25	ésteres de n-(aril/heteroarilacetil) aminoácidos, composições farmacêuticas compreendendo os mesmos, e métodos para a inibição da liberação de peptìdeo beta-amilóide e/ou de sua sìntese por uso de tais compostos.
DE3687103D1 (de)	1992-12-17	Verfahren zur herstellung von n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-l-proline.
ATE72963T1 (de)	1992-03-15	Konditionierfluessigkeiten von zahn- oder knochensubstanz.
ID1001B (id)	1996-10-10	Proses dan alat untuk fermentasi asam amino
BG97123A (bg)	1993-12-24	Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
DE68910771D1 (de)	1993-12-23	Verfahren zur Herstellung von verbessertem Proteinhydrolysat.
DE69737476D1 (de)	2007-04-26	Neuer galaninrezeptor
DE59407675D1 (de)	1999-03-04	Verfahren zur Herstellung von 6H-Dibenz-(c,e)(1,2)-oxaphosphorin-6-on
DE3681127D1 (de)	1991-10-02	Primycin enthaltendes kolloidales grundgel, verfahren zu dessen herstellung, dieses grundgel enthaltende pharmazeutische und pharmako-kosmetische kompositionen.
DE69313832D1 (de)	1997-10-16	Verfahren zur Herstellung von 2,4-Dihydroxydiphenylsulfon
ES2075107T3 (es)	1995-10-01	Composiciones que contienen ibuprofeno y s(+)-ibuprofeno, y procedimiento para su preparacion.
DE69010526D1 (de)	1994-08-18	Verfahren zur Herstellung von L-Alanin.
FR2674253B1 (fr)	1995-10-20	Composition lyophilisee pour la multiplication de sequences d'acides nucleiques.
ATE26109T1 (de)	1987-04-15	Acetylcystein-salze, ihre herstellung und verwendung.
DE69802329D1 (de)	2001-12-13	Verfahren zur Herstellung von 3,4 disubstituirten Dinitroanilinen
ES512769A0 (es)	1983-08-01	"procedimiento para la preparacion de esteres 2-metoxifenilicos de aminoacidos n-substituidos".
SE9604439D0 (sv)	1996-12-02	New receptor
DE68909118D1 (de)	1993-10-21	Verfahren zur Ausscheidung von 2,6-Dimethylnaphthalin.
FI910788A0 (fi)	1991-02-19	Syntes av lh-rh-analoger medelst temporaer minimal skydd.
ATE76081T1 (de)	1992-05-15	Verfahren zur herstellung von dipeptiden mit nterminalen nichtproteinogenen aminosaeuren.